Oral anticoagulation in peripheral vascular surgery: How intense, for how long, or at all?

Journal of Internal Medicine

Volumn 245, Issue 4, 1999, Pages 389-397

  Kretschmer, G ^a,b   Holzenbein T J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b L Boltzmann Institute of Interdisciplinary Research in Vascular Medicine   (Austria)

Author keywords

Antiplatelet treatment; Clinical trials; Oral anticoagulation; Peripheral arterial disease; Postoperative pharmacotherapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; FEMOROPOPLITEAL BYPASS; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; INTERNATIONAL STANDARD UNIT; LIMB SALVAGE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE CARE; PRIORITY JOURNAL; THROMBOSIS PREVENTION; VASCULAR SURGERY;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; THROMBOEMBOLISM; VASCULAR SURGICAL PROCEDURES;

EID: 0032939021     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00463.x     Document Type: Conference Paper

References (44)

1. Clagett PG, Graor RA, Salzman EW. Antilhrombotic therapy in peripheral arterial occlusive disease. Chest 1992; 102 (Suppl.): 516-28.
2. Berkoff HA, Levine RL. Management of vascular patients with multisystem atherosclerosis. Prog in Cardiomsc Res 1987; 29: 347-68.
3. Dormandy J. Surgical pharmacotherapy. Eur J Vasc Surg 1989; 3: 379-80.
4. Antiplatclet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br MedJ 1994; 308: 159-68.
5. Kretschmer G, Sekundärbehandlung der peripheren arteriellen Verschlußkrankheit. Antiaggregieren - Antikoagulieren (Editorial). Act Chir Austr 1992: 24: 2-4
6. Van Urk H. Kretschmer G. What is the role of oral anticoagulants and platelet inhibitors in peripheral vascular surgery? Eur J Vasc Surg 1990; 4: 553-55.
7. Gloviczki P, Hollier LH, Can graft occlusion be prevented by drugs? In: Greenhalgh RM, Jamieson CW, Nicolaides AW. eds. Vascular Surgery; Issues in Current Practice. London: Grune & Stratton. 1986:37-41.
8. Bergqvist D, Pharmacological intervention to increase patency after arterial reconstruction. In: Bergqvist D, Lindblad B. eds. Malmö: ICM AB, 1989:11-18.
9. Clagett PG for the Ad Hoc Committee on Clinical Research. Clinical research and vascular surgery. J Vasc Surg 1992: 15: 867-73.
10. Wagner O, Das Dokumentationssystein der Österr. Ges. für Gefäßchirurgie - Aufbau, Struktur und praktische Anwendung. Kongreßbericht der 5. Jahrestagung der ÖGG. Wien: H. Egermann. 1973:211-19.
11. Kretschmer G, Herbst F. Verschlu der Oberschenkelarterie. Chir Gastrocnterologie 1994: 10: 54-8.
12. Kretschmer G, Wenzl E, Schemper M et al. Orale Antikoagulation nach femoro-popliteo-cruralem Venenbypass. Der Einflu auf das Patientenüberleben unter besonderer Berücksichtigung des cardialen Risikos, der Hypertonie, und des Diabetes mellitus. Angio 1990: 12: 79-86.
13. Herbst F, Berlakovich G, Steger G, Schemper M, Polterauer P, Kretschmer G. Langzeitresultate des femoro-poplitealen und femoro-cruralen Saphenabypass: eine multivariate logistische Regressionsanalyse. Angio 1991; 13: 161-8.
14. Kretschmer G, Wenzl E, Schemper M et al. Vein bypass surgery for femoro-popliteal arteriosclerosis: influence of different risk factors on patient survival and the importance of anticoagulant treatment. Eur J Vasc Surg 1988; 2: 77-81.
15. Zekert F, Klinische Anvendung von Aggregationshemmer bei arterieller Verschlußkrankheit. In: Zekert F, ed. Thrombosen, Embolie und Aggregationshemmer in der Chirurgie. Stuttgart: Schattauer, 1975:68-72.
16. Kretschmer G, Rossmann E, Gruber E et al. Acetyl-Salicyl-Säure (ASA) nach iliacopoplitealen Eingriffen He/v Chir Acta 1990; 57: 649-53.
17. Kretschmer G, Rossmann E, Piza F et al. Value of antiplatelet therapy following repair of iliaco-femoro-popliteal occlusions. Br/Siir jl990;77A: 346.
18. Fugger R, Kretschmer G, Pratschner TH et al. Is acetylsalicylic-acid (ASA) of value in preventing occlusion following repair of iliaco-popliteal lesions and prolonging patient survival. Late evaluation of a clinical trial. J Cardiovasc Surg 1990; A23: 23.
19. Kretschmer G, Wenzl E, Schemper M et al. Influence of postoperative anticoagulant treatment on patient survival after femoro-popliteal vein bypass surgery. Lancet 1988: 1: 797-99.
20. Kretschmer G, Herbst F, Prager M et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoro-popliteal atherosclerosis. Arch Surg 1992; 127: 1112-15.
21. Pocock SJ, Simon R. Sequential treatment assignment with balancing of prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103-15.
22. Fink H. Kontingenztafelanalyse unabhängiger Daten in der Arzneimittelprüfung. Alei/i Inform Mcd 1975; 14: 212-17.
23. Ku HH, Varner R, Kullbäck S. On the analysis of multidimensional contingency tables. J Am Statist Assoc 1971; 66: 55-64.
24. Kaplan EL, Meier P. Nonparamctric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 475-81.
25. Breslow N. A generalised Kruskal-Wallis test for comparing K-samples subject to unequal patterns of censorship. Biometribi 1970; 57: 579-82.
26. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Cliemotlier Rep 1966; 50: 163-65.
27. Pocock SJ. Clinical Trials. New York: J Wiley & Sons, 1958; 176-84.
28. Cox DD. Regression models and life tables. J R Statistic Soc 1972: 34B: 187-96.
29. Antiplatelet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
30. Schomig A. Neumann FJ, Kastrati A et al A randomised comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents. NEngJ/Medl996; 334: 1084-89.
31. Hölzenbein THJ, Pomposelli FB, Miller A et al. Results of a policy with arm veins used as a first alternative to unavailable greater saphenous vein for infra-inguinal bypass. J Vasc Surg 1996:23: 130-40.
32. Underwood MJ, Moore RS. The aspirin papers. Br MedJ 1994; 308: 71-2.
33. Dormandy J, Mahir M, Ascady G. Fate of the patient with chronic leg ischemia. J Cardiovasc Surg 1989; 30: 50-57.
34. Becquemin JP for the Etude de la Ticlopidine après Pontage Femoro-Poplite and the Association Universitaire de Récherche en Chirurgie. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. N Engl J Med 1997; 337: 1726-31.
35. Schneider E, Brunner U, Bollinger A. Medikamentöse Rezidivprophylaxe nach femoropoplitealer Arterienrekon-struktion. Angio 1979: 2: 73-7.
36. De Smit P, van Urk H, Dutch oral anticoagulation trial. Act Chir Austr 1992: 24: 5-7.
37. Schwilden ED Lnngzeitantikoagiilationstherapie Gefäßchirurgischer Patienten in Holland. City?: ANGIO 1979; 2: 78-82.
38. Arfvidsson B, Lundgren F, Drott C, Schersten T, Lundholm K. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 1990: 159: 556-60.
39. Clagett PG. Antithrombotic therapy for lower extremity bypass. J Vasc Surg 1992: 15: 873-5.
40. Johnson WC, Blebea J, Cantelmo NL et al Does oral anticoagulation improve patency of vein bypasses? A prospective randomised study. 51st Annual Meeting, SVS, Boston. USA. June 1-2. 1997:44(Abstract).
41. Sixty Plus Reinfarction Study Research Group. A double blind trial to assess long term oral anticoagulation therapy in elderly after myocardial infarction. Lancet 1980; II: 989-93.
42. Fontaine R, Kim M, Kieny R. Die chirurgische Behandlung der peripheren Durchblutungsstörungen. Helv Chir Acta 1954: 21: 499-533.
43. Lawson JA, Tangelder MJD, Aigra A, Eikelboom BC. The myth of the in situ graft: superiority in infrainguinal venous bypass procedures? Results from a large prospective comparative study (BOA). Europ Soc Vasc Surg; 12th Annual Meeting. Paris. Oct 1-4. 1998, p. 138.
44. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC. Seeger JM. Warfarin improves the outcome of infrainguinal bypass grafts at high risk of failure. J Vasc Surg 1998: 28: 446-457.